DNA Damage Signaling Mediates the Functional Antagonism Between Replicative Senescence and Terminal Muscle Differentiation
Overview
Authors
Affiliations
The molecular determinants of muscle progenitor impairment to regenerate aged muscles are currently unclear. We show that, in a mouse model of replicative senescence, decline in muscle satellite cell-mediated regeneration coincides with activation of DNA damage response (DDR) and impaired ability to differentiate into myotubes. Inhibition of DDR restored satellite cell differentiation ability. Moreover, in replicative human senescent fibroblasts, DDR precluded MYOD-mediated activation of the myogenic program. A DDR-resistant MYOD mutant could overcome this barrier by resuming cell cycle progression. Likewise, DDR inhibition could also restore MYOD's ability to activate the myogenic program in human senescent fibroblasts. Of note, we found that cell cycle progression is necessary for the DDR-resistant MYOD mutant to reverse senescence-mediated inhibition of the myogenic program. These data provide the first evidence of DDR-mediated functional antagonism between senescence and MYOD-activated gene expression and indicate a previously unrecognized requirement of cell cycle progression for the activation of the myogenic program.
Millozzi F, Milan-Rois P, Sett A, Delli Carpini G, De Bardi M, Gisbert-Garzaran M Nat Commun. 2025; 16(1):577.
PMID: 39794309 PMC: 11724063. DOI: 10.1038/s41467-024-55223-9.
Tey S, Anderson R, Yu C, Robertson S, Kletzien H, Connor N Front Cell Dev Biol. 2024; 12:1481491.
PMID: 39474351 PMC: 11518775. DOI: 10.3389/fcell.2024.1481491.
Varghese S, Hernandez-De La Pena A, Dhawan S Biochem Soc Trans. 2024; 52(5):2133-2144.
PMID: 39364746 PMC: 11555696. DOI: 10.1042/BST20231519.
p66Shc signaling and autophagy impact on C2C12 myoblast differentiation during senescence.
Potes Y, Bermejo-Millo J, Mendes C, Castelao-Baptista J, Diaz-Luis A, Perez-Martinez Z Cell Death Dis. 2024; 15(3):200.
PMID: 38459002 PMC: 10923948. DOI: 10.1038/s41419-024-06582-0.
Mozzetta C, Sartorelli V, Steinkuhler C, Puri P Trends Mol Med. 2024; 30(3):278-294.
PMID: 38408879 PMC: 11095976. DOI: 10.1016/j.molmed.2024.01.007.